Co-Diagnostics Inc
(CODX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,541 | 3,535 | 4,625 | 117 | 0 |
| Receivables | 24 | N/A | 2 | 2 | 0 |
| Inventories | N/A | 9 | 45 | N/A | 0 |
| TOTAL | $3,145 | $4,452 | $5,912 | $313 | $0 |
| Non-Current Assets | |||||
| PPE Net | 163 | 166 | 140 | 154 | N/A |
| Investments And Advances | 20 | 45 | 0 | 0 | 0 |
| TOTAL | $182 | $211 | $140 | $154 | $N/A |
| Total Assets | $3,327 | $4,662 | $6,052 | $468 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 36 | 41 | 81 | 191 | 0 |
| Accrued Expenses | 211 | 577 | 586 | 1,036 | 0 |
| TOTAL | $286 | $628 | $677 | $4,674 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 39 | 11 | 11 | 11 | N/A |
| Other Non-Current Liabilities | 330 | 0 | 0 | 0 | 0 |
| TOTAL | $476 | $184 | $186 | $189 | $N/A |
| Total Liabilities | $762 | $812 | $863 | $4,863 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 410 | 410 | 409 | 397 | N/A |
| Common Shares | 12 | 12 | 12 | 10 | 0 |
| Retained earnings | -13,733 | -12,422 | -10,918 | -7,024 | 0 |
| TOTAL | $2,565 | $3,851 | $5,189 | $-4,395 | $0 |
| Total Liabilities And Equity | $3,327 | $4,662 | $6,052 | $468 | $0 |